Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies.

PURPOSE The motion of mediastinal lymph nodes may undermine local control with involved-field radiotherapy. We studied patterns of nodal and tumor motion in 41 patients with lung cancer. METHODS AND MATERIALS Four-dimensional (4D) computed tomography planning scans were retrospectively evaluated to identify patients with clearly visible mediastinal lymph nodes. One hundred nodes from 14 patients with Stage I and 27 patients with Stage III were manually contoured in all 4D computed tomography respiratory phases. Motion was derived from changes in the nodal center-of-mass position. Primary tumors were also delineated in all phases for 16 patients with Stage III disease. Statistical analysis included a multivariate mixed-effects model of grouped data. RESULTS Average 3D nodal motion during quiet breathing was 0.68 cm (range, 0.17-1.64 cm); 77% moved greater than 0.5 cm, and 10% moved greater than 1.0 cm. Motion was greatest in the lower mediastinum (p = 0.002), and nodes measuring 2 cm or greater in diameter showed motion similar to that in smaller nodes. In 11 of 16 patients studied, at least one node moved more than the corresponding primary tumor. No association between 3D primary tumor motion and nodal motion was observed. For mobile primary tumors, phase offsets between the primary tumor and nodes of two or more and three or more phases were observed for 33% and 12% of nodes, respectively. CONCLUSIONS Mediastinal nodal motion is common, with phase offsets seen between the primary tumor and different nodes in the same patient. Patient-specific information is needed to ensure geometric coverage, and adaptive strategies based solely on the primary tumor may be misleading.

[1]  Yih-Leong Chang,et al.  Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. , 2007, Chest.

[2]  Jinming Yu,et al.  Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[3]  Suresh Senan,et al.  Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[4]  Randall K Ten Haken,et al.  CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.

[5]  Suresh Senan,et al.  Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Paul J Keall,et al.  Tumor and normal tissue motion in the thorax during respiration: Analysis of volumetric and positional variations using 4D CT. , 2007, International journal of radiation oncology, biology, physics.

[7]  T. Pan,et al.  4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. , 2004, Medical physics.

[8]  C. Stevens,et al.  Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[9]  E. Yorke,et al.  Involved-field radiation therapy for inoperable non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Senan,et al.  Lung cancer: intensity-modulated radiation therapy, four-dimensional imaging and mobility management. , 2007, Frontiers of radiation therapy and oncology.

[11]  Jan-Jakob Sonke,et al.  Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. , 2008, International journal of radiation oncology, biology, physics.

[12]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[13]  A. Niemierko,et al.  Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning. , 2007, International journal of radiation oncology, biology, physics.

[14]  P. Jenkins,et al.  Analysis of the movement of calcified lymph nodes during breathing. , 2005, International journal of radiation oncology, biology, physics.

[15]  S. Senan,et al.  What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? , 2002, International journal of radiation oncology, biology, physics.

[16]  Suresh Senan,et al.  Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC. , 2005, International journal of radiation oncology, biology, physics.

[17]  Jinming Yu,et al.  A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.

[18]  Claudia I Henschke,et al.  Stage of lung cancer in relation to its size: part 2. Evidence. , 2005, Chest.

[19]  E. Noordijk,et al.  Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Suresh Senan,et al.  A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer , 2006, Radiation oncology.

[21]  S. Senan,et al.  Can mediastinal nodal mobility explain the low yield rates for transbronchial needle aspiration without real-time imaging? , 2007, Chest.

[22]  Suresh Senan,et al.  Renal mobility during uncoached quiet respiration: an analysis of 4DCT scans. , 2006, International journal of radiation oncology, biology, physics.

[23]  Lawrence B Marks,et al.  Dosimetric and clinical predictors for radiation-induced esophageal injury. , 2005, International journal of radiation oncology, biology, physics.

[24]  P. Lambin,et al.  Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[25]  R. V. van Klaveren,et al.  Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[26]  D. Verellen,et al.  Innovations in image-guided radiotherapy , 2007, Nature Reviews Cancer.

[27]  Wei Lu,et al.  Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT. , 2007, International journal of radiation oncology, biology, physics.

[28]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[29]  George Starkschall,et al.  Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. , 2007, International journal of radiation oncology, biology, physics.